4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001209191-23-055524
Chief Medical Officer acquired 82,512 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Farwell Wildon Chief Medical Officer | 2023-11-15 | Grant or award | +82,512 | 171,762 | D | ||
| Derivatives | |||||||
| Farwell Wildon Chief Medical Officer | 2023-11-15 | Grant or award · Stock Option (right to buy) | +32,131 | 32,131 | D | ||
Loading xslF345X05/doc4.xml…